These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27030614)

  • 21. [Effects of intracoronary or intravenous tirofiban administration in patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Yang XC; Zhang DP; Wang LF; Xu L; Ge YG; Wang HS; Li WM; Ni ZH; Xia K; Lian Y; Xue YL; Ma LX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):517-22. PubMed ID: 17711710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of selective infarct-related artery infusion of tirofiban on myocardial reperfusion and bleeding complications in patients with acute myocardial infarction: the SUIT-AMI trial.
    Chen Y; Zhou P; Yan H; Zhao H; Song L; Liu C; Zhao B; Chi Y; Wang S; Wang J
    J Invasive Cardiol; 2013 Aug; 25(8):376-82. PubMed ID: 23913601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
    Valgimigli M; Campo G; Malagutti P; Anselmi M; Bolognese L; Ribichini F; Boccuzzi G; de Cesare N; Rodriguez AE; Russo F; Moreno R; Biondi-Zoccai G; Penzo C; Díaz Fernández JF; Parrinello G; Ferrari R
    JACC Cardiovasc Interv; 2011 Jan; 4(1):51-62. PubMed ID: 21251629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and feasibility of a novel dosing regimen of tirofiban administered in patients with acute myocardial infarction with ST elevation before primary coronary angioplasty: a pilot study.
    Kochman W; Dobrzycki S; Nowak KS; Chlopicki S; Kralisz P; Prokopczuk P; Bachorzewska-Gajewska H; Gugala K; Niewada M; Mezynski G; Poniatowski B; Korecki J; Musial WJ
    J Thromb Thrombolysis; 2004 Apr; 17(2):127-31. PubMed ID: 15306748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Facilitated PCI by combination fibrinolysis or upstream tirofiban in acute ST-segment elevation myocardial infarction: results of the Alteplase and Tirofiban in Acute Myocardial Infarction (ATAMI) trial.
    Peters S; Truemmel M; Koehler B
    Int J Cardiol; 2008 Nov; 130(2):235-40. PubMed ID: 18055037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial effects of intracoronary tirofiban bolus administration following upstream intravenous treatment in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the ICT-AMI study.
    Zhu TQ; Zhang Q; Qiu JP; Jin HG; Lu L; Shen J; Zhao LP; Zhang RY; Hu J; Yang ZK; Shen WF
    Int J Cardiol; 2013 May; 165(3):437-43. PubMed ID: 21940058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
    Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of Thrombectomy Combined with Intracoronary Administration of Tirofiban in ST-segment Elevation Myocardial Infarction (STEMI).
    Gao L; Cao Z; Zhang H
    Med Sci Monit; 2016 Jul; 22():2699-705. PubMed ID: 27475844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upstream high-dose tirofiban does not reduce myocardial infarct size in patients undergoing primary percutaneous coronary intervention: a magnetic resonance imaging pilot study.
    Song YB; Hahn JY; Gwon HC; Kim JH; Lee SY; Choe YH; Choi SH; Choi JH; Lee SH
    Clin Cardiol; 2009 Jun; 32(6):321-6. PubMed ID: 19569068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of tirofiban maintenance duration on myocardial perfusion defect severity in anterior myocardial infarction.
    Tas MH; Simsek Z; Ayan A; Aksu U; Demirelli S; Koza Y; Lazoglu Z; Seven B; Senocak H
    Adv Ther; 2013 Sep; 30(9):834-44. PubMed ID: 24057341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influences of different dose of tirofiban for acute ST elevation myocardial infarction patients underwent percutaneous coronary intervention.
    Wang H; Feng M
    Medicine (Baltimore); 2020 Jun; 99(23):e20402. PubMed ID: 32501985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial.
    van 't Hof AW; Ernst N; de Boer MJ; de Winter R; Boersma E; Bunt T; Petronio S; Marcel Gosselink AT; Jap W; Hollak F; Hoorntje JC; Suryapranata H; Dambrink JH; Zijlstra F;
    Eur Heart J; 2004 May; 25(10):837-46. PubMed ID: 15140531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of early high-loading-dose tirofiban on platelet activity in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Ren XN; Wang LF; Wang MS; Xu L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Feb; 40(2):131-5. PubMed ID: 22490713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marked reduction of early stent thrombosis with pre-hospital initiation of high-dose Tirofiban in ST-segment elevation myocardial infarction.
    Heestermans AA; Van Werkum JW; Hamm C; Dill T; Gosselink AT; De Boer MJ; Van Houwelingen G; Hoorntje JC; Koopmans PC; Ten Berg JM; Van 't Hof AW
    J Thromb Haemost; 2009 Oct; 7(10):1612-8. PubMed ID: 19682233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes.
    Yip HK; Wu CJ; Chang HW; Hsieh YK; Fang CY; Chen SM; Chen MC
    Chest; 2003 Sep; 124(3):962-8. PubMed ID: 12970024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial).
    Taglieri N; Saia F; Guiducci V; Tondi S; Conrotto F; Marrozzini C; Rocchi G; Biagini E; Reggiani ML; Giacometti P; Piovaccari G; Manari A; Marzocchi A;
    Am J Cardiol; 2009 Mar; 103(6):785-90. PubMed ID: 19268732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term effect of upstream administration in comparison to deferred injection of tirofiban on patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Jia Z; Guo M; Zhang YQ; Liang HQ; Song Y
    J Interv Cardiol; 2013 Aug; 26(4):332-9. PubMed ID: 23844823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of tirofiban before primary angioplasty on initial coronary flow and early ST-segment resolution in patients with acute myocardial infarction.
    Cutlip DE; Ricciardi MJ; Ling FS; Carrozza JP; Dua V; Garringer J; Giri S; Caputo RP
    Am J Cardiol; 2003 Oct; 92(8):977-80. PubMed ID: 14556878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy and safety of tirofiban use after successful percutaneous coronary intervention for patients with moderate to high risk non-ST segment elevation acute coronary syndromes].
    Zhang Y; Gao CY; Zhu ZY; Liu HZ; Wang XP; Yang HH; Li MW; Wang XQ; Qi DT; Hu DY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Sep; 41(9):731-5. PubMed ID: 24331798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of tirofiban combined with dalteparin or unfractionated heparin in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction patients.
    Li WM; Yang XC; Wang LF; Ge YG; Wang HS; Xu L; Ni ZH; Zhang DP
    Chin Med J (Engl); 2011 Oct; 124(20):3275-80. PubMed ID: 22088520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.